Exosomes of Porphyromonas gingivalis-Infected Macrophages Impair the Endothelial Barrier and Angiogenesis In Vitro

Yanling Zhou1,2,3, Yihua Huang1,2,3, Xiaomin Lv1,2,3

  • 1Hosiptal of Stomatology, Sun Yat-Sen University, Guangzhou, Guangdong, China.

Oral Diseases
|March 30, 2026
PubMed
Abstract

Insights

Exosomes from Porphyromonas gingivalis-infected macrophages cause endothelial dysfunction by suppressing the Akt/mTOR pathway, offering new therapeutic targets for oral inflammatory diseases.

Area of Science:

  • Oral biology and immunology
  • Endothelial cell biology
  • Exosome biology

Background:

  • Endothelial dysfunction is central to periodontal disease and apical periodontitis.
  • The role of macrophage-derived exosomes in these conditions is not well understood.

Purpose of the Study:

  • To investigate the impact of exosomes from Porphyromonas gingivalis-infected macrophages on endothelial cells.
  • To elucidate the underlying molecular mechanisms of exosome-mediated endothelial dysfunction.

Main Methods:

  • Isolation and verification of exosomes from infected (P.g-Exos) and uninfected (Con-Exos) macrophages.
  • Assessment of P.g-Exos effects on human umbilical vein endothelial cells (HUVECs) including permeability, adhesion, migration, and angiogenesis.
  • Analysis of inflammatory marker expression (TNF-α, IL-6) and investigation of the Akt/mTOR pathway.

Main Results:

  • P.g-Exos inhibited HUVEC migration and angiogenesis, increased vascular permeability, and promoted leukocyte adhesion.
  • P.g-Exos induced the release of pro-inflammatory factors from HUVECs.
  • Endothelial dysfunction induced by P.g-Exos was partially mediated by the suppression of the Akt/mTOR pathway.

Conclusions:

  • Exosomes derived from inflammatory macrophages contribute to endothelial dysfunction in oral inflammatory diseases.
  • Targeting the Akt/mTOR pathway offers a potential therapeutic strategy for these conditions.
  • This study provides novel insights into the pathogenesis of oral inflammatory diseases and potential treatment avenues.